These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3195422)
1. Addiction and prenatal screening. Monroe L Am Fam Physician; 1988 Dec; 38(6):46. PubMed ID: 3195422 [No Abstract] [Full Text] [Related]
2. Meconium drug screening to detect prenatal substance abuse. Wildman KM; Mohl V; Houston R; Allerheiligen D J Fam Pract; 1996 Nov; 43(5):501-2. PubMed ID: 8917151 [No Abstract] [Full Text] [Related]
3. Drug addiction and pregnancy: a different perspective. Custo GM; Saitto C; Minozzi M Acta Eur Fertil; 1988; 19(2):105-6. PubMed ID: 3223193 [No Abstract] [Full Text] [Related]
4. Commentary: screening as a tool for engagement. Chasnoff IJ; McGourty R J Perinatol; 2006 Apr; 26(4):261. PubMed ID: 16570084 [No Abstract] [Full Text] [Related]
5. Detection of prenatal drug exposure in the pregnant woman and her newborn infant. Ostrea EM NIDA Res Monogr; 1992; 117():61-79. PubMed ID: 1620211 [No Abstract] [Full Text] [Related]
6. Underdetection of substance abuse. Lurio J; Younge R; Selwyn PA N Engl J Med; 1991 Oct; 325(14):1045-6. PubMed ID: 1886628 [No Abstract] [Full Text] [Related]
7. Perinatal addiction: the effects of maternal narcotic and nonnarcotic substance abuse on the fetus and neonate. Chasnoff IJ; Burns WJ; Schnoll SH NIDA Res Monogr; 1984 Mar; 49():220-6. PubMed ID: 6434963 [No Abstract] [Full Text] [Related]
8. [Pregnancy of a drug-abuser]. Halmesmäki E Duodecim; 2000; 116(14):1513-8; quiz 1519, 1471. PubMed ID: 12001470 [No Abstract] [Full Text] [Related]
9. [Pregnancy monitoring in the woman with drug addiction. Role of the home midwife]. Carenco H; Alessio D; Cagnol M; Jeannot D; Demandrille J Soins Gynecol Obstet Pueric Pediatr; 1989 May; (96):21-2. PubMed ID: 2749448 [No Abstract] [Full Text] [Related]
10. Measurement of substance use during pregnancy: methodologic issues. Day NL; Wagener DK; Taylor PM NIDA Res Monogr; 1985; 59():36-47. PubMed ID: 3929131 [No Abstract] [Full Text] [Related]
11. Role of biologic markers in epidemiologic studies of prenatal drug exposure: issues in study design. Bracken MB; Leaderer B; Belanger K NIDA Res Monogr; 1992; 117():41-60. PubMed ID: 1620210 [No Abstract] [Full Text] [Related]
12. [Drugs and pregnancy]. Halmesmäki E; Kari A Duodecim; 1998; 114(20):2109-14. PubMed ID: 11717737 [No Abstract] [Full Text] [Related]
14. Chemical assessment in maternity care. Campinha-Bacote J; Bragg EJ MCN Am J Matern Child Nurs; 1993; 18(1):24-8. PubMed ID: 8423734 [No Abstract] [Full Text] [Related]
15. Roadblocks to identifying drug use in pregnant women. Trute J J Am Diet Assoc; 1992 Jun; 92(6):676. PubMed ID: 1607561 [No Abstract] [Full Text] [Related]
16. Letter: Salicylates and perinatal mortality in aborigines. Collins E; Turner G Med J Aust; 1975 Apr; 1(16):517. PubMed ID: 1134410 [No Abstract] [Full Text] [Related]
17. The pregnant adolescent and drugs. Schneider LE Semin Adolesc Med; 1986 Sep; 2(3):231-4. PubMed ID: 3496642 [No Abstract] [Full Text] [Related]
18. Prenatal substance use in a Western urban community. Buchi KF; Varner MW West J Med; 1994 Nov; 161(5):483-6. PubMed ID: 7810126 [TBL] [Abstract][Full Text] [Related]
19. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health. Koren G; Hutson J; Gareri J Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086 [TBL] [Abstract][Full Text] [Related]
20. Assessment of perinatal substance abusers: experiences of one Perinatal-20 project. Haller DL; Ingersoll KS NIDA Res Monogr; 1996; 166():143-62. PubMed ID: 8818170 [No Abstract] [Full Text] [Related] [Next] [New Search]